Page 3 - Dr Reddys Laboratories Ltd News

Axis Bank, Voda Idea: 28 Nifty 500 stocks reclaim 200-DMA today; full list

Among others Dr. Reddy's, Apollo Hospitals, M&M Finance, Muthoot Finance, Tata Power, Balrampur Chini and Sammaan Capital soared up to 20% from recent lows to cross the long-term average, shows data.

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt

Companies including Dr. Reddy's Laboratories, Sun Pharma, Zydus Lifesciences, Natco Pharma, Alkem Laboratories, and Torrent Pharmaceuticals have developed their own formulations

Analyst suggests Nifty strategy; bets on Oil India, Dr Reddy's Labs

Ajit Mishra of Religare Broking recommends Nifty strategy and two stocks to buy; check details here

Nifty Pharma index hits 52-week high; Ipca, Aurobindo rally up to 4%

In the past one month, the Nifty Pharma index has rallied 4.5 per cent, as against 7.8 per cent decline in the benchmark Nifty 50.

Stocks to Watch today: UltraTech Cement, Dr Reddy's Labs, Tata Power, GNFC

Stocks to Watch today, March 9, 2026: HDFC Life Insurance, Tata Power, GNFC, Avenue Supermarts, and Meesho are among the top stocks to remain in focus today

Stocks to Watch: OMCs, Garden Reach, Petronet LNG, JK Tyre, DCX Systems

Stocks to Watch today: OMCs, Garden Reach, Petronet LNG, SAMHI Hotels, DCX Systems, JK Tyre and Dr Reddy's are among the stocks to watch today, March 06, 2026

Breakout stocks: BEL, Dr Reddy's, Triveni can gain up to 12%, says chartist

Bullish signs on charts: Hitesh Tailor of Choice Broking explains that BEL has witnessed a decisive symmetrical triangle breakout, while Dr Reddy's and Triveni Engineering saw 'Golden Crossovers'.

Nifty Pharma index soars 7% thus far in February; nears 52-week high

Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.

Dr Reddy's likely to launch generic semaglutide Obeda in India in March

Hyderabad-based Dr Reddy's has applied to trademark the Obeda brand and logo, a government filing showed

Stocks to Watch today, Feb 25: RIL, Schaeffler, Aditya Infotech, Hindalco

Stocks to Watch today, February 25, 2026: Schaeffler India, Aditya Infotech, RVL are among few stocks that will be in focus

Dr Reddy's enters hormone replacement therapy segment with $32 mn buy

Dr Reddy's Laboratories has forayed into hormone replacement therapy segment by acquiring trademarks of specialty brands, Progynova and Cyclo-Progynova and related assets, for India from UK-headquartered Mercury Pharma Group for USD 32.15 million, according to a company statement. Progynova (estradiol valerate) is an oral hormone replacement therapy indicated for the treatment of estrogen deficiency symptoms and for the prevention of postmenopausal osteoporosis. Cyclo-Progynova (estradiol valerate and norgestrel) is a combined hormone replacement therapy indicated for the treatment of estrogen deficiency symptoms, providing both estrogen and progestogen components. As per IQVIA MAT December 2025, the brand recorded sales of Rs 100 crore. The acquisition strengthens Dr Reddy's gynaecology portfolio and marks a strategic entry into the hormone replacement therapy segment, the drug firm stated. "The acquisition will serve as the spearhead of our expansion into the HRT segment, ...

Stocks to Watch today, Feb 19: Dr Reddy's Labs, HUL, Cochin Shipyard, DLF

Stocks to Watch today, February 19, 2025: Dr Reddy's Labs, Hindustan Unilever, NCC, DLF, and Jindal Saw are some of the key stocks to watch today